[Developmental aspects of angioimmunoblastic lymphadenopathy. Apropos of 3 cases].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006942:Hypergammaglobulinemia / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008198:Lymph Nodes / Q000473:pathology; D008206:Lymphatic Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D010950:Plasma Cells
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D001323:Autoantibodies; D007166:Immunosuppressive Agents
Aspects évolutifs de la lymphadénopathie angio-immunoblastique. A propos de trois observations